HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Fassetta Selected Research

1,9-dideoxyforskolin

3/2004Apoptosis to necrosis switching downstream of apoptosome formation requires inhibition of both glycolysis and oxidative phosphorylation in a BCL-X(L)- and PKB/AKT-independent fashion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Fassetta Research Topics

Disease

1Neoplasms (Cancer)
02/2007
1Colorectal Neoplasms (Colorectal Cancer)
02/2007
1Necrosis
03/2004

Drug/Important Bio-Agent (IBA)

1Proto-Oncogene Proteins c-metIBA
02/2007
1beta CateninIBA
02/2007
1Calcibiotic Root Canal SealerIBA
02/2007
11,9-dideoxyforskolinIBA
03/2004
1Apoptosomes (Apoptosome)IBA
03/2004
1Adenosine Triphosphate (ATP)IBA
03/2004
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
03/2004
1ColforsinIBA
03/2004